ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1206

$645K Total Retail Price of All Prescriptions

Rank: 64 out of 1206

484 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,052 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 675 621 1 1
OMEPRAZOLE 568 405 2 3
FUROSEMIDE 507 433 3 5
LISINOPRIL 472 402 4 4
LEVOTHYROXINE SODIUM 452 316 5 2
METFORMIN HCL 335 293 6 10
PRAVASTATIN SODIUM 300 215 7 21
AMLODIPINE BESYLATE 297 263 8 6
TRAMADOL HCL 272 198 9 17
ATENOLOL 262 218 10 14
POTASSIUM CHLORIDE 240 178 11 12
HYDROCODONE-ACETAMINOPHEN 231 116 S3 12 7
GABAPENTIN 214 181 13 18
CITALOPRAM HBR 212 189 14 16
METOPROLOL SUCCINATE 186 186 15 15
WARFARIN SODIUM 186 160 15 8
ISOSORBIDE MONONITRATE ER 166 156 17 40
METOPROLOL TARTRATE 160 118 18 9
MIRTAZAPINE 150 111 19 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 117 20 27
SPIRONOLACTONE 145 111 21 41
ATORVASTATIN CALCIUM 133 125 22 13
MORPHINE SULFATE ER 131 16 S2 23 114
ALENDRONATE SODIUM 128 123 24 19
RANITIDINE HCL 121 53 25 23
FENOFIBRATE 117 82 26 56
ZOLPIDEM TARTRATE 114 77 27 25
LOSARTAN POTASSIUM 111 98 28 20
LANTUS 107 96 29 38
GLIMEPIRIDE 106 101 30 34
FAMOTIDINE 104 65 31 65
CRESTOR 98 71 32 30
TRIAMTERENE-HCTZ 89 66 33 33
CLOPIDOGREL 89 75 33 48
RAMIPRIL 81 58 35 96
KLOR-CON 10 79 68 36 93
NABUMETONE 78 45 37 91
ROPINIROLE HCL 78 70 37 77
CARVEDILOL 73 60 39 32
PROAIR HFA 72 35 40 49
ALLOPURINOL 72 69 40 24
HYDROCHLOROTHIAZIDE 71 49 42 11
MELOXICAM 71 67 42 35
METOCLOPRAMIDE HCL 71 41 42 127
CYMBALTA 69 17 45 63
NOVOLOG 68 55 46 100
DIGOXIN 67 51 47 43
HYDROXYCHLOROQUINE SULFATE 67 55 47 305
NEXIUM 66 46 49 47
INSULIN SYRINGE 66 59 49 111
AZITHROMYCIN 62 43 51 46
TAMSULOSIN HCL 62 62 51 26
PREDNISONE 62 47 51 28
FENTANYL 61 54 S2 54 51
SOTALOL 61 61 54 177
VERAPAMIL ER 58 48 56 97
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 49 57 82
DIOVAN HCT 54 34 58 112
COMBIVENT 53 38 59 150
ENALAPRIL MALEATE 53 30 59 45
POLYETHYLENE GLYCOL 3350 52 33 61 31
LANTUS SOLOSTAR 51 41 62 85
TRAZODONE HCL 51 46 62 37
SERTRALINE HCL 50 49 64 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.